Literature DB >> 17696225

Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation.

Guo-Zhong Gong1, Jie Cao, Yong-Fang Jiang, Yang Zhou, Bo Liu.   

Abstract

AIM: To study the effect of Hepatitis C virus non-structural 5A (HCV NS5A) on IFNalpha induced signal transducer and activator of transcription-1 (STAT1) phosphorylation and nuclear translocation.
METHODS: Expression of STAT1 Tyr701 phosphorylation at different time points was confirmed by Western blot, and the time point when p-STAT1 expressed most, was taken as the IFN induction time for further studies. Immunocytochemistry was used to confirm the successful transient transfection of NS5A expression plasmid. Immunofluorescence was performed to observe if there was any difference in IFNalpha-induced STAT1 phosphorylation and nuclear translocation between HCV NS5A-expressed and non-HCV NS5A-expressed cells. Western blot was used to compare the phosphorylated STAT1 protein of the cells.
RESULTS: Expression of HCV NS5A was found in the cytoplasm of P(CNS5A-transfected ) Huh7 cells, but not in the PRC/CMV transfected or non-transfected cells. STAT1 Tyr701 phosphorylation was found strongest in 30 min of IFN induction. STAT1 phosphorylation and nuclear import were much less in the presence of HCV NS5A protein in contrast to P( RC/CMV-transfected ) and non-transfected cells under fluorescent microscopy, which was further confirmed by Western blot.
CONCLUSION: HCV NS5A expression plasmid is successfully transfected into Huh7 cells and HCV NS5A protein is expressed in the cytoplasm of the cells. IFN-alpha is able to induce STAT1 phosphorylation and nuclear translocation, and this effect is inhibited by HCV NS5A protein, which might be another possible resistance mechanism to interferon alpha therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696225      PMCID: PMC4205308          DOI: 10.3748/wjg.v13.i30.4080

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).

Authors:  S Pellegrini; I Dusanter-Fourt
Journal:  Eur J Biochem       Date:  1997-09-15

Review 2.  Molecular virology of hepatitis C virus.

Authors:  B Clarke
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

3.  Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism.

Authors:  Ren-Jye Lin; Bi-Lan Chang; Han-Pang Yu; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.

Authors:  Sonja M Best; Keely L Morris; Jeffrey G Shannon; Shelly J Robertson; Dana N Mitzel; Gregory S Park; Elena Boer; James B Wolfinbarger; Marshall E Bloom
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A.

Authors:  Y Tanji; T Kaneko; S Satoh; K Shimotohno
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.

Authors:  S L Tan; H Nakao; Y He; S Vijaysri; P Neddermann; B L Jacobs; B J Mayer; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines.

Authors:  Keng-Hsin Lan; Keng-Li Lan; Wei-Ping Lee; Meei-Ling Sheu; Ming-Yuan Chen; Yung-Lu Lee; Sang-Hue Yen; Full-Young Chang; Shou-Dong Lee
Journal:  J Hepatol       Date:  2006-12-14       Impact factor: 25.083

8.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.

Authors:  M J Gale; M J Korth; N M Tang; S L Tan; D A Hopkins; T E Dever; S J Polyak; D R Gretch; M G Katze
Journal:  Virology       Date:  1997-04-14       Impact factor: 3.616

9.  [Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin].

Authors:  P Veillon; C Payan; C Gaudy; A Goudeau; F Lunel
Journal:  Pathol Biol (Paris)       Date:  2004-11

Review 10.  Hepatitis C virus biology.

Authors:  C Giannini; C Bréchot
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

View more
  9 in total

Review 1.  Impact of host and virus genome variability on HCV replication and response to interferon.

Authors:  Cameron J Schweitzer; T Jake Liang
Journal:  Curr Opin Virol       Date:  2013-07-06       Impact factor: 7.090

2.  Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.

Authors:  Celia Perales; Nathan M Beach; Isabel Gallego; Maria Eugenia Soria; Josep Quer; Juan Ignacio Esteban; Charles Rice; Esteban Domingo; Julie Sheldon
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

3.  Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.

Authors:  Kattareeya Kumthip; Pattranuch Chusri; Nikolaus Jilg; Lei Zhao; Dahlene N Fusco; Hong Zhao; Kaku Goto; Du Cheng; Esperance A Schaefer; Leiliang Zhang; Chansom Pantip; Satawat Thongsawat; Amornrat O'Brien; Lee F Peng; Niwat Maneekarn; Raymond T Chung; Wenyu Lin
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

4.  Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling.

Authors:  Ryuichi Sugiyama; Asako Murayama; Sayuri Nitta; Norie Yamada; Megumi Tasaka-Fujita; Takahiro Masaki; Hussein Hassan Aly; Masaaki Shiina; Akihide Ryo; Koji Ishii; Takaji Wakita; Takanobu Kato
Journal:  Oncotarget       Date:  2017-12-21

Review 5.  STAT1 and pathogens, not a friendly relationship.

Authors:  Imen Najjar; Remi Fagard
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

6.  Heat shock protein 72 is associated with the hepatitis C virus replicase complex and enhances viral RNA replication.

Authors:  Yin-Ju Chen; Yu-Hsuan Chen; Lu-Ping Chow; Ya-Hui Tsai; Pei-Hong Chen; Chi-Ying F Huang; Wei-Tzu Chen; Lih-Hwa Hwang
Journal:  J Biol Chem       Date:  2010-07-02       Impact factor: 5.157

7.  Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Authors:  Chen Yang; Xinhao Zhao; Dakang Sun; Leilei Yang; Chang Chong; Yu Pan; Xiumei Chi; Yanhang Gao; Moli Wang; Xiaodong Shi; Haibo Sun; Juan Lv; Yuanda Gao; Jin Zhong; Junqi Niu; Bing Sun
Journal:  Cell Mol Immunol       Date:  2015-02-16       Impact factor: 11.530

8.  γ-H2AX+CD8+ T lymphocytes cannot respond to IFN-α, IL-2 or IL-6 in chronic hepatitis C virus infection.

Authors:  Matthew Hoare; Arun Shankar; Meera Shah; Simon Rushbrook; William Gelson; Susan Davies; Arne Akbar; Graeme J M Alexander
Journal:  J Hepatol       Date:  2012-12-17       Impact factor: 25.083

Review 9.  The role of HCV proteins on treatment outcomes.

Authors:  Kattareeya Kumthip; Niwat Maneekarn
Journal:  Virol J       Date:  2015-12-15       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.